Summary
Pre-clinical evaluation has demonstrated that 2-[4-(((3,5-dimethylanilino)carbonyl)methyl)phenoxy]-2-methylpropionic acid (RSR13) acts as an allosteric effector of haemoglobin (Hb). RSR13 binding to Hb results in decreased haemoglobin–oxygen (Hb–O2) affinity, improved tumour oxygenation, and enhanced radiation-induced cell killing in several experimental tumour systems. In the present work, ex vivo clonogenic survival analyses are applied in two murine tumour systems to characterize the relationship between the magnitude of decrease in Hb–O2 affinity and radiosensitization, the influence of inspired pO2 upon this effect, and the efficacy of combining RSR13 and radiation during a course of repeated radiation exposures. For FSaII tumours in C3H mice breathing air, 100 mg kg–1 RSR13 administered intraperitoneally produced an enhancement ratio (ER) of 1.3, but there was marked desensitization at a RSR13 dose of 300 mg kg–1 (ER 0.6). The most likely reason for the increased radioresistance was insufficient oxygen loading of Hb in the pulmonary circulation due to reduced haemoglobin–oxygen affinity because carbogen breathing combined with 300 mg kg–1 RSR13 reversed the effect and produced an ER of 1.8. In SCCVII tumours in C3H mice irradiated with eight fractions of 2.5 Gy over 4 days, the surviving fraction was reduced to 58–67% of control values when RSR13 was combined with radiation on days 1 and 2, days 3 and 4, or days 1–4. These results confirm that combining RSR13 and irradiation within a fractionated course of clinically relevant low-dose exposures provides significant radiosensitization. Additional preclinical experimentation is needed to define better the optimum dose-scheduling conditions for clinical applications.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Abraham, D. J., Peascoe, R. A., Randad, R. S. & Panikker, J. (1992a). X-ray diffraction study of di and tetra-ligated T-state hemoglobin from high salt crystals. J Mol Biol 227: 480–492.
Abraham, D. J., Wireko, F. C., Randad, R. S., Poyart, C., Kister, J., Bohn, B. B., Liard, J. F. & Kunert, M. P. (1992b). Allosteric modifiers of hemoglobin: 2-[4-[[(3, 5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats. Biochemistry 31: 9141–9149.
Brady, L. W., Plenk, H. P., Hanley, J. A., Glassburn, J. R., Kramer, S. & Parker, R. G. (1981). Hyperbaric oxygen for carcinoma of the cervix – stages IIB, IIIB and IVA: results of a randomized study by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 7: 991–998.
Brizel, D. M., Sibley, G. S., Prosnitz, L. R., Scher, R. & Dewhirst, M. W. (1997). Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38: 285–290.
Brown, J. M. & Lemmon, M. J. (1990). Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumor. Cancer Res 50: 7745–7749.
Bush, R. S., Jenkin, R. D. T., Allt, W. E. C., Beale, F. A., Bean, H., Dembo, A. J. & Pringle, J. F. (1978). Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer 37 (suppl. III): 302–306.
Dewhirst, M. W., Ong, E. T., Rosner, G. L., Rehmus, S. W., Shan, S., Braun, R. D., Brizel, D. M. & Secomb, T. W. (1996). Arteriolar oxygenation in tumour and subcutaneous arterioles: effects of inspired air oxygen content. Br J Cancer 74 (suppl. XXVII): S241–S246.
Dische, S., Anderson, P. J., Sealy, R. & Watson, E. R. (1983). Carcinoma of the cervix – anaemia, radiotherapy and hyperbaric oxygen. Br J Radiol 56: 251–255.
Dorie, M. J., Menke, D. & Brown, J. M. (1993). Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen. Int J Radiat Oncol Biol Phys 28: 145–150.
Evans, J. C. & Bergsjo, P. (1965). The influence of anaemia on the results of radiotherapy in carcinoma of the cervix. Radiology 84: 709–717.
Fletcher, G. L., Lindberg, R. D., Caderao, J. B. & Wharton, J. T. (1977). Hyperbaric oxygen as a radiotherapeutic adjuvant in advanced carcinoma of the uterine cervix: preliminary results of a randomized trial. Cancer 39: 617–623.
Gatenby, R. A., Kessler, H. B., Rosenblaum, J. S., Coia, L. R., Moldofsky, P. J., Hartz, W. H. & Broder, G. J. (1988). Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 14: 831–838.
Gerweck, L. E., Koutcher, J. A., Zaidi, S. T. & Seneviratne, T. (1992). Energy status in the murine FSaII and MCaIV tumors under aerobic and hypoxic conditions: an in-vivo and in-vitro analysis. Int J Radiat Oncol Biol Phys 23: 557–561.
Goda, F., O’Hara, J. A., Rhodes, E. S., Liu, K. J., Dunn, J. F., Bacic, G. & Swartz, H. M. (1995). Changes of oxygen tension in experiment tumors after a single dose of X-ray irradiation. Cancer Res 55: 2249–2252.
Hall, E. J. (1994). Radiobiology for the Radiologist, 4th edn, pp. 133–152, JB Lippincott: Philadelphia
Hirst, D. G. & Wood, P. J. (1987). The influence of haemoglobin affinity for oxygen on tumour radiosensitivity. Br J Cancer 55: 487–491.
Hirst, D. G. & Wood, P. J. (1989). Chlorophenoxy acetic acid derivatives as hemoglobin modifiers and tumor radiosensitizers. Int J Radiat Oncol Biol Phys 16: 1183–1186.
Hirst, D. G., Wood, P. J. & Schwartz, H. C. (1987). The modification of hemoglobin affinity for oxygen and tumor radiosensitivity by antilipidemic drugs. Radiat Res 112: 164–172.
Hockel, M., Knoop, C., Schlenge, K., Vorndran, B., Baubmann, E., Mitze, M., Knapstein, P. G. & Vaupel, P. (1993). Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 26: 43–50.
Horsman, M. R., Chaplin, D. J. & Overgaard, J. (1991). The use of blood flow modifiers to improve the treatment response of solid tumors. Radiother Oncol 20(suppl.): 47–52.
Horsman, M. R., Khalil, A. A., Siemann, D. W., Grau, C., Hill, S. A., Lynch, E. M., Chaplin, D. J. & Overgaard, J. (1994). Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation. Int J Radiat Oncol Biol Phys 29: 439–442.
Jain, R. K. (1988). Determinants of tumor blood flow. Cancer Res 48: 2641–2658.
Kavanagh, B. D., Khandelwal, S. R., Schmidt-Ullrich, R. K., Roberts, J. D., Pearlman, A. D., Shaw, E. G., Venitz, J. & Gerber, M. J. (1997). A phase Ib study to evaluate repeated daily intravenous doses of RSR13 administered to cancer patients receiving concurrent radiation therapy (abstract). Proceedings of the 39th Annual ASTRO Meeting. Int J Radiat Oncol Biol Phys 39: 330S
Khandelwal, S. R., Randad, R. S., Lin, P. S., Meng, H., Pittman, R. N., Kontos, H. A., Choi, S. C., Abraham, D. J. & Schmidt-Ullrich, R. (1993). Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation. Am J Physiol 265: H1450–H1453.
Khandelwal, S. R., Lin, P. S., Hall, C. E., Truong, Q. T., Lu, J., Laurent, J. J., Joshi, G. S., Abraham, D. J. & Schmidt-Ullrich, R. K. (1996). Increased radiation response of FsaII fibrosarcomas in C3H mice following administration of an allosteric effector of hemoglobin–oxygen affinity. Radiat Oncol Invest 4: 51–59.
Moulder, J. E. & Rockwell, S. (1984). Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys 10: 695–712.
Nordsmark, M., Overgaard, M. & Overgaard, J. (1996a). Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41: 31–39.
Nordsmark, M., Hoyer, M., Keller, J., Nielsen, O. S., Jensen, O. M. & Overgaard, J. (1996b). The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. Int J Radiat Oncol Biol Phys 35: 701–708.
Okunieff, P. G., Koutcher, J. A., Gerweck, L., McFarland, E., Hitzig, B., Urano, M., Brady, T., Nueringer, L. & Suit, H. D. (1986). Tumor size dependent changes in a murine fibrosarcoma: use of in vivo 32P NMR for non-invasive evaluation of tumor metabolic status. Int J Radiat Oncol Biol Phys 12: 793–799.
Overgaard, J. (1994). Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors. Oncol Res 6: 509–518.
Overgaard, J., Hansen, H. S., Andersen, A. P., Hjelm-Hansen, M., Jorgensen, K., Sandberg, E., Berthelsen, A., Hammer, R. & Pedersen, M. (1989). Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study. Int J Radiat Oncol Biol Phys 16: 1065–1068.
Randad, R. S., Mahran, M. A., Mehanna, A. S. & Abraham, D. J. (1991). Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure–allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents. J Med Chem 34: 752–757.
Rice, L., Urano, M. & Suit, H. D. (1980). The radiosensitivity of a murine fibrosarcoma as measured by three cell survival assays. Br J Cancer 41(suppl. 4): 240–244.
Siemann, D. W. & Macler, L. M. (1986). Tumor radiosensitization through reductions in hemoglobin affinity. Int J Radiat Oncol Biol Phys 12: 1295–1297.
Siemann, D. W., Hill, R. P., Bush, R. S. & Chhabra, P. (1979). The in vivo radiation response of an experimental tumor: the effect of exposing tumor-bearing mice to a reduced oxygen environment prior to but not during irradiation. Int J Radiat Oncol Biol Phys 5: 61–68.
Teicher, B. A., Ara, G., Emi, Y., Kakeji, Y., Ikebe, M., Maehara, Y. & Buxton, D. (1996). RSR13: effects on tumor oxygenation and response to therapy. Drug Dev Res 38: 1–11.
Van Putten, L. M. & Kallman, R. F. (1968). Oxygenation status of a transplantable tumor during fractionated radiotherapy. J Natl Cancer Inst 40: 441–451.
Ward, A. J. & Dixon, B. (1979). Carcinoma of the cervix: results of a hyperbaric oxygen trial associated with the use of the cathetron. Clin Radiol 30: 383–387.
Wireko, F. C., Kellogg, G. E. & Abraham, D. J. (1991). Allosteric modifiers of hemoglobin. 2. Crystallographically determined binding sites and hydrophobic binding/interaction analysis of novel hemoglobin oxygen effectors. J Med Chem 34: 758–767.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Khandelwal, S., Kavanagh, B., Lin, PS. et al. RSR13, an allosteric effector of haemoglobin, and carbogen radiosensitize FSAII and SCCVII tumours in C3H mice. Br J Cancer 79, 814–820 (1999). https://doi.org/10.1038/sj.bjc.6690130
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690130
Keywords
This article is cited by
-
Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo
Cancer Chemotherapy and Pharmacology (2004)
